MedTrace Logo

AMH, Glucose Intolerance and Metabolic Syndrome in PCOS

NCT02676518 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2016-02-08

No results posted yet for this study

Summary

Association between serum anti-Mullerian hormone (AMH) level and prevalence of glucose intolerance and metabolic syndrome in women with polycystic ovary syndrome (PCOS)

Conditions

  • Polycystic Ovary Syndrome

Interventions

OTHER

serum

Serum for serum anti-Mullerian hormone, 2-hour 75 gram oral glucose tolerance test and lipid profiles

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Dhirapong Charoenvidya, MD · Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02676518 on ClinicalTrials.gov